Extramedullary hematopoiesis (EMH) occurs in approximately 15% of cases of thalassemia. Paraspinal mass of extramedullary hematopoiesis are a rare compensatory process in intermediate and severe thalassemia. We present a case of a paravertebral extramedullary hematopoiesis (EMH) with a spinal cord compression in a 27-year-old man with beta thalassemia intermediate who complaint of paresis in lower extremities and progression up to umbilical level.

Paravertebral (EMH) although rare, should always be considered in the differential diagnosis of any upper motor neuron disease condition in patients with thalassemia and therefore appropriate studies should perform to investigate the probable paravertebral ectopic marrow before any surgical intervention.

Saadat P, Ahangar AA, Sotouneh N, Alijanpour S (2016) Spinal Cord Compression Due to Extramedullary Hematopoiesis in a 27-Year-Old Man with Beta Thalassemia Intermedia: A Case Report. J Neurol Disord Stroke 4(1): 1109.

Extramedullary hematopoiesis (EMH) occurs commonly in patients with severe thalassemia who receive inadequate treatment. The incidence of EMH in patients with thalassemia intermedia may reach up to 20%, compared to polytransfused thalassemia major patients where the incidence remains <1% [1]. Besides the usual regions of hematopoiesis, blood cells can be formed in unusual sites like the liver, spleen and lymph nodes to meet the demands of hematopoiesis [2]. There are a few reports where EMH has involved some rare places such as the perirenal and paravertebral regions, paranasal sinuses, clivus, meninges, spinal epidural spaces, prostate, adrenals, pleura, breast, thymus, kidney, sweat gland, broad ligament and retroperitoneal space [2]. This unusual phenomenon, especially when it involves the spinal cord can lead to neurological deficits [3]. A paraspinal location for the hematopoietic tissue occurs in 11–15% of cases with EMH [1].

A 27-year-old Iranian man, known case of beta thalassemia intermedia, presented with the complaint of paresis in lower extremities during the last three months, with recent progression to sever paraparesis and hypoesthesia in both lower extremities up to umbilical level in abdomen and bladder and bowel incontinence.

He had a positive family history of major thalassemia in his siblings.

He had no blood transfusions, had common bile duct stone, and had past history of motor accident leading to open fracture in left leg and skull fracture in his past medical history. He consumed only folic acid.

On physical examination he was pale, prominent skull deformity and had splenomegaly. Neurological examination showed normal mental status examination, and normal cranial nerve exam. In sensory examination, his light touch and pinprick & temperature.

Appreciation and joint position sense were impaired in lower extremities with sensory level up to umbilical zone. Romberg test was impaired. He had spastic paraparesis and (3-4/5) muscle power in proximal and distal muscles of both legs. His deep tendon reflexes showed increase in lower extremities but no clonus was detected. Babinski’s sign was present in both sides. Above finding were compatible with diagnosis of upper motor neuron diseases (myelopathy) in lower thoracic spinal cord segment.

On admission, his laboratory investigation showed hemoglobin 10.6 g/dL, white blood cell count 6.3× 109 /L, platelet count 81 × 109 /L, mean corpuscular volume 78 fl.

Magnetic resonance imaging (MRI) of his thoracolumbar spinal cord revealed multiple paravertebral masses with rib expansion, intraspinal extension and soft tissue masses, suggestive of extramedullary hematopoiesis or neurofibromatosis (Figures 1,2).

Figure 1: Sagittal T1w and T2w images show a large epidural mass occupying the posterior part of the spinal canal, Extending from T5 to T11 level. The mass is displacing the spinal cord anteriorly and compressing it.

Figure 2: Axial T2w images show that the cord is flattened and displaced anteriorly by the epidural mass. In addition, the large bilateral paravertebral mass and expanded posterior ends of ribs are seen.

After doing MRI, core needle biopsy was recommended by radiologist. CT guided paravertebral mass biopsy was done and pathologic examination of specimen was compatible with hematopoietic tissue.

Macroscopically, the specimen measured 0.3 cm in length and was creamy and rubbery. Microscopically, the specimen was fibro connective tissue accompanied by foci of trilineages hematopoietic cells.

After the confirming of diagnosis, patient was treated by hydroxyurea 500 mg two times a day. He showed slow recovery from the signs and symptoms of paresis and relieved his incontinency after 3 months follow up.

Extramedullary haematopoiesis (EMH) is a compensatory phenomenon that occurs when erythrocyte production is diminished or destruction is accelerated. (EMH) can occur in many disorders including thalassemia, polycythemia rubra vera, myelofibrosis, haemolytic anemia and other hemoglobinopathies.

EMH is usually microscopic and commonly involves the liver, spleen and lymph nodes. Thoracic manifestation is less common and consists of paravertebral soft tissue masses. The masses represent extrusion of the marrow through the thinned cortex of the posterior ribs. It usually has a predilection for the lower thoracic spine where the limited mobility and narrow spinal canal predisposes itself to spinal cord compression [4].

Most cases present with paraparesis, sensory impairment and occasionally sphincter disturbances .complete paraplegia has been reported very rarely in thalassemia and occurs more frequently in polycythemia rubra vera and sickle cell anemia [5]. The diagnostic procedure of choice is MRI which characteristically shows an isointense mass with a high signal intensity rim on T1_weighted images and a hyperintense mass on T2_weighted images. The diagnosis is based on strong clinical suspicion in the presense of diffuse bone marrow hyperplasia along with symmetric paraspinal and epidural masses .Although we had performed needle biopsy to establish the definite diagnosis in this case, in some studies the non-invasive procedures such as 18F-FLT PET/CT and 99mTc-SC SPECT/CT Scintigraphy is recommended to establish the definite diagnosis [6].

Treatment options for cord compression are surgery, radiation therapy, blood transfusion, hudroxyurea or various combinations therapy. Due to the extreme rarity of this condition direct comparisson between various treatments modalities are not possible. Whereas most cases presenting with paraparesis have been treated with either surgery or radiotherapy, we hereby report a case of thalassemia intermedia with paraparesis treated successfully with only drug therapy. A few authors have reported good results with the use of hydroxyurea along with hyper transfusion [7].

In report of 2 cases of extramedullary hematopoiesis in the American Journal of the Medical Sciences [8], the authors have recommended to include extramedullary hematopoiesis among the differential diagnosis of tumor-like masses in patients with hematologic diseases. In this report the cases were treated without surgery. Ileri and colleague treated a 9-year-old patient suffering from thalassemia intermedia and presenting spinal cord compression with radiation therapy followed by hydroxyurea [9].

The drug, in addition to its cytostatic effects, has a favourable effect on fetal haemoglobin production. Gamberini et al, treated a 24 year old patient of thalassemia intermedia with paraplegia due to EMH, with hydroxyurea 1000 mg/day for 5 months change to; 500mg/day up to 25 months [7]. Since our patient showed mild spinal cord compression, hydroxyurea was considered. Our patient showed rapid and near complete recovery with hydroxyurea alone despite having long standing paraparesis.

This case report showed that although rare, a paravertebral EMH should always be considered in the differential diagnosis of any upper motor neuron disease condition in patients with thalassemia and therefore appropriate studies performed to investigate the probable paravertebral ectopic marrow. We conclude that drug therapy may be the optimal therapeutic approach in such cases with mild paraparesis.

We would like to thank the staff of neurology department of Rouhani Hospital of Babol Medical Sciences University.

1. Haidar R, Mhaidi H, Taher AT. Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia. Eur Spine J. 2010; 19: 871–878.

2. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010; 115: 1886-1892.

3. Ittipunkul N, Martin T, Siriwanasan R, Olanratanachai K, Rootman J. Extra-medullary hematopoiesis causing bilateral optic atrophy in beta thalassemia/Hb E disease. J Med Assoc Thai. 2007; 90: 809-812.

4. Tan TC, Tsao J, Cheung FC. Extramedullary haemopoiesis in thalassemia intermedia presenting as paraplegia. J Clin Neurosci. 2002; 9: 721-725.

5. Salehi SA, Koski T, Ondra SL. Spinal cord compression in beta-thalassemia: case report and review of the literature. Spinal Cord. 2004; 42: 117-123.

6. Anand Zade, Nilendu Purandare, Venkatesh Rangarajan, Sneha Shah, Archi Agrawal, Jhaet Ashish, et al. Noninvasive Approaches to Diagnose Intrathoracic Extramedullary Hematopoiesis: 18F-FLT PET/ CT and 99mTc-SC SPECT/CT Scintigraphy. Clinical Nuclear Medicine. 2012; 37: 788–789.

7. Gamberini MR, Fortini M, De Sanctis V. Paraplegia due to spinal cord compression by extramedullary erythropoietic tissue in a thalassaemia intermedia patient with gynecomastia secondary to cirrhosis: successful treatment with hydroxyurea. Pediatr Endocrinol Rev. 2004; 2: 316-318.

8. Roberto Castelli, Giovanna Graziadei, Mehran Karimi, Maria Domenica Cappellini. Intrathoracic Masses Due to Extramedullary Hematopoiesis. The American Journal of the Medical Sciences: 2004; 328: 299-303.

9. Talia Ileri, Fatih Azk, Mehmet Ertem, Zumrut Uysal, Sevgi Gozdasoglu. Extramedullary Hematopoiesis with Spinal Cord Compression in a Child with Thalassemia Intermedia. Journal of Pediatric Hematology/ Oncology. 2009; 31: 681-683.